- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
SK Biopharmaceuticals
Market Cap: ₩9.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩114,100.00
7D
5.5%
1Y
-4.6%
JW Shinyak
Market Cap: ₩76.1b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,414.00
7D
-1.4%
1Y
7.5%
JW Lifescience
Market Cap: ₩206.9b
Provides national infusion solutions in South Korea and internationally.
A234080
₩13,560.00
7D
1.2%
1Y
24.4%